文献速递医学教育与科研方法流行病学与生物统计

出版商对已发表研究诚信问题的回应不一致:证据与改进建议

Inconsistency in publishers' responses to integrity concerns about published research. Evidence and suggested improvements.
PubMed 文献 · J Clin Epidemiol · 2025-08-29

该研究通过叙事综述梳理出版商对研究诚信问题回应的文献,并结合个人经验及对单一研究组172篇临床试验论文诚信问题提出5年后出版商回应的新分析。结果显示出版商回应常缓慢、不完整且不透明,相似问题处理时间和结果差异显著,从无编辑行动到全部撤稿不等。

要点

  • 现有证据表明,出版商对研究诚信问题的回应普遍缓慢、不完整且不透明。
  • 对同一研究组172篇临床试验论文的相似诚信问题,出版商处理时间和结果差异显著。
  • 回应结果从无编辑行动到全部撤稿不等,原因未知,需协作透明流程改进。

核心结论

  • 出版商对期刊发表内容诚信问题通知的回应在时间安排和编辑决定性质上均显著不一致。
  • 不一致的原因未知,但可通过涉及出版商诚信人员和具有发表诚信专长的学者的协作透明流程来解决。
  • 理解不同结果的原因可能有助于改进,从而增强生物医学文献的可信度。

研究设计与样本

  • 叙事综述,梳理报告出版商对研究诚信问题回应的出版物。
  • 结合广泛个人经验及对单一研究组172篇临床试验论文诚信问题提出5年后出版商回应的新分析。

主要发现

  • 现有证据报告,临床和临床前学科中出版商对诚信问题的回应常见缓慢、不完整且不透明。
  • 同时向出版商提出关于大量期刊论文的非常相似担忧时,解决时间差异显著,结果从无编辑行动到全部撤稿不等。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To collate, review, and comment upon publishers' response to integrity concerns. STUDY DESIGN AND SETTING: We conducted a narrative review of publications reporting the responses of publishers to concerns about the integrity of research published in their journals. We also drew upon extensive personal experience and a new analysis of publisher responses to integrity concerns about 172 clinical trial publications by a single research group 5 years after the concerns were raised simultaneously with affected publishers. RESULTS: Existing evidence reports that slow, incomplete, and opaque responses from publishers to integrity concerns are common, in both clinical and preclinical disciplines. When we raised very similar concerns about a large set of journal articles simultaneously with publishers, times to resolution varied markedly, and outcomes ranged from no editorial action to all papers retracted. CONCLUSION: Publishers' responses to notification of concerns about the integrity of publications in their journals are markedly inconsistent, both in their timing and the nature of their editorial decisions. The reasons for these inconsistencies are unknown but could be addressed by a collaborative and transparent process involving publisher integrity staff and academics with expertise in publication integrity. Understanding the reasons for the disparate outcomes is likely to facilitate improvements which will enhance the trustworthiness of the biomedical literature. PLAIN LANGUAGE SUMMARY: Existing evidence reports that publishers are slow to assess concerns about the reliability of research publications, and their assessments produce markedly inconsistent outcomes. Our finding of widely disparate outcomes of publisher assessments of overlapping concerns about 172 clinical trials by a single research group reinforces this point. Improving the timeliness, transparency, and systematicity of publisher assessments is likely to enhance the reliability of published research.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Grey A, Avenell A, Gaby A, et al. Inconsistency in publishers' responses to integrity concerns about published research. Evidence and suggested improvements. J Clin Epidemiol. 2025. PMID: 40769259. doi:10.1016/j.jclinepi.2025.111918

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。